Kreshya Sudsanoh

Kreshya Sudsanoh

Auto-generated profile, based on publicly available information

Kreshya Sudsanoh

Department of Emergency Medicine Phang Nga Hospital Mueang District Phang Nga 82000 Thailand

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
PDF file
KSKreshya Sudsanoh
Kreshya Sudsanoh
TLThanin Lokeskrawee
Thanin Lokeskrawee
NPNatthaphon Pruksathorn
Natthaphon Pruksathorn
SLSuppachai Lawanaskol
Suppachai Lawanaskol
JPJayanton Patumanond
Jayanton Patumanond
PSPimploy Suriyanusorn
Pimploy Suriyanusorn
Background: A previous study developed a predictive model for identifying positive findings on computed tomography (CT) brain imaging in patients with non-traumatic seizures. One key predictor was the Glasgow Coma Scale (GCS), categorized into three groups (≤ 8, 9 - 13, >13). However, in real-world practice, some bedridden patients have low baseline GCS, which may lead to overprediction and unnecessary CT imaging. The original model yielded a false positive of 16.6%, exceeding the predefined threshold of less than 15%. This study aimed to improve the model by replacing categorized GCS with GCS change from baseline to reduce false positives below 15%, while maintaining false negatives below 5%. Methods: This diagnostic predictive study included patients with non-traumatic seizures who underwent CT brain imaging at the emergency department between November 2019 and November 2023. The original predictors were retained, with GCS change from baseline replacing the categorized GCS. Multivariable logistic regression analysis was used to estimate multivariable odds ratios. Discriminative performance was assessed using the area under the receiver operating characteristic (AuROC) curve. A trade-off between sensitivity and specificity was applied to identify a probability cut-off that met the target for false positives and false negatives. The revised model was named the “SeizCT optimized model”. Results: Of the 625 patients included, 18.9% had positive CT findings. The majority were male (74.9%) with a mean age of 55 years. The SeizCT optimized model incorporated six predictors: prior stroke (> 3 months), current cancer, GCS change from baseline, alcohol withdrawal symptoms, epilepsy, and focal neurological deficit. The model demonstrated an AuROC of 0.8221 (95% confidence interval (CI): 0.7813, 0.8629). Using a threshold probability of 22.57%, it outperformed the original model (AuROC of 0.8156; 95% CI: 0.7598, 0.8746) with narrower confidence intervals. It achieved a false negative of 4.8% and a false positive of 14.4%. Conclusions: The SeizCT optimized model showed improved performance over the original tool, reducing both false positives and false negatives within the predefined thresholds. External validation is recommended.

1 November 2025 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
PDF file
NPNatthaphon Pruksathorn
Natthaphon Pruksathorn
TLThanin Lokeskrawee
Thanin Lokeskrawee
JYJarupa Yaowalaorng
Jarupa Yaowalaorng
SLSuppachai Lawanaskol
Suppachai Lawanaskol
JPJayanton Patumanond
Jayanton Patumanond
PSPimploy Suriyanusorn
Pimploy Suriyanusorn
Background: Previous studies developed the SeizCT primer and optimized models, both demonstrating similar values for the area under the receiver operating characteristic curve (AuROC). The optimized model incorporates Glasgow Coma Scale (GCS) change from baseline instead of categorized GCS at emergency department (ED) presentation. This study aimed to validate these two models for predicting positive computed tomography (CT) findings in patients with non-traumatic seizures. Methods: A retrospective cross-sectional study was conducted among adult patients (≥ 18 years) with non-traumatic seizures who underwent CT brain imaging in the ED at Lampang Hospital. Data were collected between December 2023 and July 2024 based on parameters from the SeizCT primer and optimized models. External validation compared model performance using AuROC, calibration, decision curve analysis (DCA), and confusion matrices. Results: The validation cohort included 312 patients (210 (67.3%) male; mean age 53 years). Positive CT findings were found in 58 patients (18.6%). The SeizCT primer model had an AuROC of 0.7218 (95% confidence interval (CI): 0.6476, 0.7961), while the SeizCT optimized model achieved 0.7394 (95% CI: 0.6663, 0.8124). An equivalence test showed statistically equivalent discrimination between the two models (P < 0.015), with the optimized model demonstrating better calibration (slope: 0.582 vs. 0.701; P = 0.002; observed-to-expected ratio: 0.934 vs. 0.971; P = 0.030). Conclusions: Both models demonstrated fair to acceptable discrimination after external validation. The SeizCT optimized model is recommended, as it showed superior calibration and its incorporation of GCS change from baseline offers greater clinical applicability.